← Leaderboards
Paul Douglas Godfrin
Veramorph, Llc
$399,985
Attributed
$399,985
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$399,985 · 1
By mechanism
R44$399,985 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adjuvant”
- Warwick Britton · University Of Sydney$10,964,476
- Philip Felgner · University Of California-Irvine$10,234,165
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
Research focus
AdjuvantBreast Cancer PatientCdk4 GeneCellsChemistryClinical EfficacyClinical TranslationCombined Modality TherapyCommercializationComparative EfficacyComplementDiagnosisDisease ProgressionDosageDoseDrug Delivery SystemsEarly DiagnosisEffectivenessEfficacy EvaluationEfficacy StudyEsr1 GeneEstrogen Receptor PositiveEstrogen ReceptorsAcceleration